FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 63 filers reported holding FOGHORN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,093,395 | -28.7% | 1,018,679 | +0.4% | 0.00% | – |
| Q2 2023 | $7,145,157 | +12.8% | 1,014,937 | -0.7% | 0.00% | – |
| Q1 2023 | $6,336,183 | -2.4% | 1,021,965 | +0.4% | 0.00% | – |
| Q4 2022 | $6,494,126 | -25.3% | 1,017,888 | +0.5% | 0.00% | – |
| Q3 2022 | $8,691,000 | -36.6% | 1,012,922 | +0.5% | 0.00% | – |
| Q2 2022 | $13,703,000 | +4.5% | 1,007,589 | +17.1% | 0.00% | – |
| Q1 2022 | $13,109,000 | -32.1% | 860,770 | +1.9% | 0.00% | – |
| Q4 2021 | $19,318,000 | +65.1% | 844,691 | +0.6% | 0.00% | – |
| Q3 2021 | $11,699,000 | +60.3% | 839,917 | +22.8% | 0.00% | – |
| Q2 2021 | $7,296,000 | +35.9% | 683,778 | +67.9% | 0.00% | – |
| Q1 2021 | $5,369,000 | -34.3% | 407,334 | +1.0% | 0.00% | – |
| Q4 2020 | $8,178,000 | – | 403,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $13,458,000 | 4.37% |
| Birchview Capital, LP | 314,143 | $3,352,000 | 2.00% |
| Flagship Pioneering Inc. | 12,674,120 | $135,233,000 | 1.73% |
| Monashee Investment Management LLC | 530,581 | $5,661,000 | 0.68% |
| Artal Group S.A. | 1,720,720 | $18,360,000 | 0.37% |
| Alphabet Inc. | 500,901 | $5,345,000 | 0.11% |
| Casdin Capital, LLC | 216,216 | $2,307,000 | 0.06% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 84,000 | $896,000 | 0.01% |
| NewSquare Capital LLC | 5,000 | $53,000 | 0.01% |
| FMR LLC | 2,540,434 | $27,106,000 | 0.00% |